Diabetes Mellitus, Type 2: all 9,590 studies
Page 79 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01407003Phase 1/2
- Albiglutide Thorough ECG Study in Healthy VolunteersCompletedNCT01406262Phase 1
- Trial Investigating the Safety of NNC 0113-0987 in Healthy Male SubjectsCompletedNCT01405261Phase 1
- The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 DiabetesCompletedNCT01404676Phase 4
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01403025
- Lifestyle Intervention in Patients With New Onset Type 2 Diabetes.CompletedNCT01402388Not applicable
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 DiabetesCompletedNCT01399645Phase 2
- Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering EfficacyCompletedNCT01398592Phase 4
- INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With MacroalbuminuriaCompletedNCT01398423Phase 2
- A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilCompletedNCT01398267Phase 1
- Maximising the Taste and Health Value of Plant Food ProductsCompletedNCT01397942Not applicable
- Assessment of Liver Glucose Metabolism in Diabetic SubjectsCompletedNCT01397279Not applicable
- Pioglitazone and Metformin in Diabetic ChildrenCompletedNCT01396564Phase 1/2
- Liraglutide Treatment to Patients With Severe Renal InsufficiencyCompletedNCT01394341Phase 4
- Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 DiabetesCompletedNCT01393808Phase 2
- Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 DiabetesCompletedNCT01393275Not applicable
- Liraglutide and Insulin Therapy in Patients With Type 2 DiabetesStatus unknownNCT01392898Not applicable
- Biospecimens for Identification of Diseases of the Pancreas.CompletedNCT01392027Not applicable
- Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix DefinitionCompletedNCT01390610
- A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard TabletCompletedNCT01388153Phase 1
- YKL-40 and Complications in Type 2 DiabetesCompletedNCT01387984
- The Effectiveness of Resistance Exercise for Glycemic Control in Type 2 Diabetes Mellitus PatientsCompletedNCT01387334Phase 2
- Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in LatinaCompletedNCT01387165
- Multicenter Research Study to Build a Repository to Study Chronic Diseases in IndianaActive, not recruitingNCT01386801
- Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesCompletedNCT01386671Phase 3
- Multiple Ascending Dose Trial of BYK324677 in Healthy VolunteersCompletedNCT01386541Phase 1
- A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)CompletedNCT01386099Phase 2
- Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 DiabetesCompletedNCT01384058Phase 4
- Outreach for Diabetes CureCompletedNCT01384045Not applicable
- Use of a Computer-Assisted Decision Support (CADS) System in Management of Patients With Type 2 DiabetesStatus unknownNCT01382264Not applicable
- A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes MellitusCompletedNCT01381887Phase 1
- Thyroid Study Type 2 Diabetes Mellitus (T2DM)Status unknownNCT01379170Phase 4
- Effect of Lycopene and Isoflavones on Glucose MetabolismWithdrawnNCT01377961Not applicable
- Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsCompletedNCT01377935
- Effects of Different Types of Exercise Interventions in Patients With Type 2 DiabetesStatus unknownNCT01377558Not applicable
- A Comparison of Two Initial Dosing FormulasCompletedNCT01377155Not applicable
- ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With MicroalbuminuriaCompletedNCT01375322Phase 4
- Glucolipotoxicity and Type 2 DiabetesCompletedNCT01375270Not applicable
- Nutritional Therapy for Diabetic CardiomyopathyCompletedNCT01373814
- A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic PatientsTerminatedNCT01372163Phase 1
- Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532CompletedNCT01369602Phase 1
- A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
- Effect of the Chromium Nicotinate on Type 2 DiabetesStatus unknownNCT01368328Phase 3
- Macronutrients and Gut Hormone SecretionCompletedNCT01366794Not applicable
- A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its AbsorptionCompletedNCT01366287Phase 1
- TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up StudyCompletedNCT01364350
- The Effect of Green Tea Extract on Type 2 Diabetes With HyperlipidemiaCompletedNCT01360567Phase 3
- Metformin Treatment, Renal Function and Lactic AcidosisCompletedNCT01358994
- A Study of RO6807952 in Patients With Diabetes Mellitus Type 2CompletedNCT01358929Phase 1
- Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 DiabeticsCompletedNCT01357876Phase 1
- 10 Prescriptions an Hour. Group Treatment and Physical Activity Referral in a Primary Health Care SettingCompletedNCT01357304Not applicable
- Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 DiabetesCompletedNCT01357252Phase 3
- Effect of Bosentan on Endothelial Function in Patients With Type 2 DiabetesCompletedNCT01357109Phase 2
- Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 DiabetesCompletedNCT01356381Phase 4
- Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in KoreaCompletedNCT01355718
- Management of Type-2 Diabetic Patients Treated With Insulin During the RamadanCompletedNCT01354925Phase 4
- Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin TherapyCompletedNCT01353469Phase 3
- Metformin in Women With Type 2 Diabetes in Pregnancy TrialCompletedNCT01353391Phase 3
- Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)Status unknownNCT01353066Phase 2/3
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndiaCompletedNCT01351922
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01351675Phase 3
- Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes SplicingCompletedNCT01349387Not applicable
- Effects of 3 Months of Supervised Exercise TrainingStatus unknownNCT01349166Not applicable
- Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2CompletedNCT01346046
- Evaluation of SCOUT DS in Subjects With Type 2 DiabetesCompletedNCT01346033
- Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01345734
- UCSD Take Charge StudyCompletedNCT01345500Not applicable
- Effects of Telemonitoring and Telemedicine Service for Type 2 Diabetes CareCompletedNCT01345435Not applicable
- The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 DiabetesStatus unknownNCT01344928Not applicable
- Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)CompletedNCT01342939
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes MellitusStatus unknownNCT01342042Phase 2
- Genetic Variation in the Transporters and Hypoglycemic AgentsStatus unknownNCT01341795
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and InsulinCompletedNCT01341717Phase 4
- Drug-drug Interaction Study(CKD-501, Amlodipine)CompletedNCT01341392Phase 1
- Relationship Between Gestational Diabetes and Type 2 DiabetesStatus unknownNCT01340924
- A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic DiseasesCompletedNCT01340911Phase 1
- TREAT (Telemedicine for Reach, Education, Access, and Treatment)CompletedNCT01339208Not applicable
- Organization Program of DiabEtes INsulIN ManaGementStatus unknownNCT01338376Phase 4
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver DiseasesStatus unknownNCT01337440Phase 4
- Regional Fat Depots and Insulin ResistanceCompletedNCT01336777
- Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination TreatmentCompletedNCT01336751Phase 3
- Glucophage XR® Observational StudyTerminatedNCT01336673
- Gene Expression Profiles and Metformin Efficacy in Type 2 DiabetesStatus unknownNCT01334684Not applicable
- A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT01334203Phase 4
- Point of Care HbA1c as a Screening Test for Type 2 Diabetes in First NationsStatus unknownNCT01333176Not applicable
- Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs RosiglitazoneCompletedNCT01332370
- Drug-drug Interaction Study (CKD-501, Ketoconazole)CompletedNCT01330563Phase 1
- The Effect of Gastric Bypass Surgery on DiabetesCompletedNCT01330251
- Bridging the Gap by Transitional CareCompletedNCT01330121Not applicable
- Effects of Caloric Restriction on Fetuin-A and Cardiovascular Risk FactorsCompletedNCT01329822Not applicable
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world SettingCompletedNCT01326598
- Vitamin D and Omega-3 Inhibit Metabolic SyndromeCompletedNCT01326442Phase 3
- Post Prandial Glucose Control Proof-of-PrincipleCompletedNCT01326299Phase 2/3
- African American Children, Glycemic Control, and Type 2 DiabetesCompletedNCT01325987Not applicable
- Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 DiabeticsCompletedNCT01324921Phase 2/3
- Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01324505Phase 1
- The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital StudyStatus unknownNCT01323114Not applicable
- Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation IndexesStatus unknownNCT01322711Phase 4
- Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes MellitusStatus unknownNCT01319734Phase 1
- Effects of Saxagliptin on Endothelial FunctionCompletedNCT01319357Phase 3